Racial Differences in Long-Term Outcomes after Percutaneous Coronary Intervention with Paclitaxel-Eluting Coronary Stents

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?

(2010) Sara D. Collins et al.   CIRCULATION

Insurance Type Influences the Use of Drug-Eluting Stents

(2010) Michael A. Gaglia et al.   JACC-Cardiovascular Interventions

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

(2010) Elvin Kedhi et al.   LANCET

Reporting and representation of race/ethnicity in published randomized trials

(2009) Jeffrey S. Berger et al.   AMERICAN HEART JOURNAL

Racial Disparities in Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stents

(2009) Michael A. Gaglia et al.   AMERICAN JOURNAL OF CARDIOLOGY

Late Clinical Events After Drug-Eluting Stents

(2009) Martin B. Leon et al.   JACC-Cardiovascular Interventions

Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent

(2008) Mark A. Turco et al.   JACC-Cardiovascular Interventions